Ethics and Consent When Managing Patients with ADHD
Dr Indrani Banerjee works as a Community Paediatric Consultant in Harrow Community Paediatric Services employed by Central and North West London NHS Foundation Trust.
She graduated from Calcutta Medical College, India. She completed her training in paediatrics in the UK specialising in Neurodevelopmental Paediatrics and developed a special interest in neurodisability. She completed her MD from University College London in “Outcome studies of effects of interventions in early life”. She is currently completing a Master’s degree in Medical Ethics and Law at Keele University.
Working in a large multidisciplinary team, her areas of interest are paediatric neurodisability
particularly cerebral palsy, epilepsy, ADHD, Autism Spectrum Disorder and learning disability and
transition services for children and young people with disability into adult life.
She is the North London Area Officer for Royal College of Paediatrics and Child Health. She lives with her family in St Albans and enjoys spending time travelling, reading, watching movies and walking the family dog.
What will the webinar cover?
Key learning objectives
- To examine the evidence base for melatonin in paediatric ASD and practical considerations when prescribing pharmacotherapy for paediatric insomnia
- To help with effective ADHD patient management by exploring the ethics and consent for managing ADHD patients
- To highlight the impacts of ineffectively managing neurodevelopmental disorders in children and young people
- To explore common complaints regarding ADHD assessment and treatment, outlining effective management strategies to avoid